BioInsights - Cell therapy bioprocessing and analytics: today’s key tools and innovation requirements to meet future demand - spotlight

CELL & GENE THERAPY INSIGHTS

Cell therapy bioprocessing and analytics: today’s key tools and innovation requirements to meet future demand

John Paul Tomtishen III

Guest Editor:

John Paul Tomtishen III, Director of Manufacturing, Technical Operations at Legend Biotech Co.

November 2020

Download full spotlight

Celyad Oncology’s case study: validation approach for accelerated mycoplasma testing

S Snykers

16 February 2021

Webinars on Demand: Expert Commentary

Read more
Streamlining and optimizing viral vector bioprocess and analytical development

J Tarnowski,

N Kotsopoulou,

K Patel et al.

19 January 2021

Expert Roundtable

Read more
Abbreviated in-house qualification of real time mycoplasma detection kit

S Viswanathan

7 January 2021

On Demand Webinar

Read more
Celyad Oncology’s case study: validation approach for accelerated mycoplasma testing

S Snykers

7 January 2021

On Demand Webinar

Read more
Streamlining and optimizing viral vector bioprocess and analytical development

J Tarnowski,

N Kotsopoulou,

K Patel et al.

22 December 2020

Expert Roundtable Video

Watch now
Cell therapy bioprocessing and analytics: today’s key tools and innovation requirements to meet future demand

J Tomtishen III

1 December 2020

Foreword

Read more
De-risking the final formulation, fill and finish step in cell therapy manufacturing: considerations for an automated solution

D Sethi,

A Cunningham

26 November 2020

Innovator Insight

Read more
Measurement: the central nervous system of a quality manufacturing line for tissue engineering and regenerative medicine products

M McCorry,

B Robinson-Zeigler,

R McFarland et al.

25 November 2020

Expert Insight

Read more
A cell therapy media fill protocol for validation of aseptic processing of cord blood

F DeDino,

K Vincent,

D DiNello et al.

24 November 2020

Methodology Paper

Read more
Addressing pain points in iPSC-derived cell therapy manufacture and scale-up

B Marques

24 November 2020

Interview

Read more
Industrializing allogeneic cell therapy bioprocessing: devising streamlined solutions to complex challenges

L Raviv

23 November 2020

Interview

Read more
The role of flow cytometry in advanced therapy medicinal products

T Nastos

20 November 2020

Expert Insight

Read more
γδ T cell therapy: devising a manufacturing-friendly bioprocess

S O'Farrell

17 November 2020

Interview

Read more
Challenges & trends in stem cell-derived extracellular vesicle bioprocessing

J Escobar Ivirico

12 November 2020

Interview

Read more
Limiting variability to achieve reproducibility in cell manufacturing

A Lamontagne,

A Fesnak

11 November 2020

Expert Insight

Read more
Process development: how to win the race in cell & gene therapy

R Baghirzade

4 November 2020

Editorial

Read more
The right time to move to an automated manufacturing system like the Cocoon platform: the when, the why, and the how

Matt Hewitt, PhD, Senior Director, Scientific Services, Cell and Gene Therapy, Charles River Laboratories

Donna Rill, Chief Technology Officer at Triumvira Immunologics Inc

3 December 2020

Webinar

Watch now
Focus on allogeneic CAR-Ts manufacturing challenges and solutions

Marcos Langtry, Head of Allogeneic Cell Therapy Commercial Development, Lonza Pharma & Biotech

Alex Sargent, Scientist at Lonza Pharma & Biotech

Behnam Baghbaderani, Global Head, Process Development, Emerging Technologies at Lonza Pharma & Biotech

5 November 2020

Webinar

Watch now